InsidersTradesSigma
Explore the complete record of transactions filed by Matthews Judith M., Chief Financial Officer. Officer active across 1 companies, notably Iterum Therapeutics plc. In total, 2 disclosures have been published. Total volume traded: €18k. The latest transaction was disclosed on 11 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Judith M. Matthews is the Chief Financial Officer at Iterum Therapeutics plc. She is responsible for the financial management of the company, including financial planning and reporting. With a strong background in finance, Judith ensures that Iterum meets its financial objectives while complying with applicable regulations. Her expertise is essential for strategic decision-making.